Techno Medica : Non-consolidated Financial Results for the Three Months Ended June 30,2022 (Under Japanese GAAP)

Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.

August 3, 2022

Non-consolidated Financial Results

for the Three Months Ended June 30,2022

(Under Japanese GAAP)

Company name:	Techno Medica Co., Ltd.
Listing:	Tokyo Stock Exchange
Securities code:	6678
URL:	http://www.technomedica.co.jp
Representative:	Masatomo Saneyoshi, President and CEO
Inquiries:	Kazuto Tsugawa, Director and General Manager of Corporate Management Division
Telephone:	[phone]

Scheduled date to file quarterly securities report:	August 9, 2022
Scheduled date to commence dividend payments:	―
Preparation of supplementary material on quarterly financial results: None
Holding of quarterly financial results briefing:	None

(Yen amounts are rounded down to millions, unless otherwise noted.)

1. Non-consolidated financial results for the Three months ended June 30,2022 (from April 1,2022 to June 30,2022)

(1) Non-consolidated operating results (cumulative)		(Percentages indicate year-on-year changes.)
	Net sales		Operating profit	Ordinary profit	Profit
Nine months ended	Millions of yen		%	Millions of yen		%	Millions of yen	%	Millions of yen	%
June 30,2022	1,786		△11.3	121		△50.5	129	△48.2	87	△48.9
June 30,2021	2,014		19.9	246		207.6	249	196.8	171	189.8
	Basic earnings	Diluted earnings
	per share		per share
Nine months ended			Yen			Yen
June 30,2022			10.37			―
June 30,2021			20.07			―
(2) Non-consolidated financial position
	Total assets	Net assets	Equity-to-asset ratio
As of	Millions of yen	Millions of yen		%
June 30,2022			17,371			15,232		87.7
June 30,2021			18,508			15,650		84.6
Reference: Equity
As of June 30,2022:		¥15,232 million
As of June 30,2021:		¥15,650 million

2. Cash dividends

		Annual dividends per share
	First quarter-end	Second quarter-end		Third quarter-end		Fiscal year-end	Total
	Yen	Yen		Yen		Yen	Yen
Fiscal year ended	―	0.00		―		60.00	60.00
March 31, 2022
Fiscal year ending	―
March 31, 2023
Fiscal year ending
March 31, 2023		0.00		―		55.00	55.00
(Forecast)

Note: Revisions to the forecast of cash dividends most recently announced: None

* Notes

1. Adoption of accounting treatment specific to the preparation of quarterly non-consolidated financial statements: None
2. Changes in accounting policies, changes in accounting estimates, and restatement
3. 1. Changes in accounting policies due to revisions to accounting standards and other regulations: None
   2. Changes in accounting policies due to other reasons: None
   3. Changes in accounting estimates: None
   4. Restatement: None
4. Number of issued shares (common shares)
5. 1. Total number of issued shares at the end of the period (including treasury shares)

As of June 30,2022	8,760,000 shares
As of March 31,2022	8,760,000 shares

(ii) Number of treasury shares at the end of the period

As of June 30,2022	341,451 shares
As of March 31,2022	339,751 shares

1. Average number of shares outstanding during the period (cumulative from the beginning of the fiscal year)

Nine months ended June 30,2022	8,419,107 shares
Nine months ended June 30,2021	8,519,315 shares

• Quarterly financial results reports are exempt from quarterly review conducted by certified public accountants or an audit corporation.
• Proper use of earnings forecasts, and other special matters
  Earnings forecasts contained in these disclosure materials are based on available information to the company and assumptions believed to be reasonable by management. This is not a promise or guarantee by the company that it will achieve these goals. Actual results may differ substantially due to several factors such as economic situation, market trend, exchange rates and other factors.

		(Thousands of yen)
	As of March 31, 2022	As of June 30, 2022
Assets
Current assets
Cash and deposits	11,523,507	11,314,260
Notes receivable - trade	30,587	69,559
Electronically recorded monetary claims -	533,349	554,141
operating
Accounts receivable - trade	3,088,090	2,017,216
Merchandise and finished goods	909,427	938,591
Work in process	191,018	214,417
Raw materials and supplies	128,854	143,213
Prepaid expenses	36,791	36,642
Other	31,124	7,359
Total current assets	16,472,750	15,295,401
Non-current assets
Property, plant and equipment
Buildings	1,199,326	1,216,126
Accumulated depreciation	△674,876	△684,759
Buildings, net	524,450	531,367
Structures	2,577	2,577
Accumulated depreciation	△2,386	△2,392
Structures, net	191	185
Machinery and equipment	350,019	350,019
Accumulated depreciation	△228,589	△234,011
Machinery and equipment, net	121,429	116,007
Tools, furniture and fixtures	292,694	304,136
Accumulated depreciation	△233,612	△241,055
Tools, furniture and fixtures, net	59,081	63,081
Land	787,326	787,326
Construction in progress	-	12,409
Total property, plant and equipment	1,492,479	1,510,377
Intangible assets
Telephone subscription right	1,177	1,177
Patent right	1,099	1,041
Software	30,739	28,188
Total intangible assets	33,017	30,407
Investments and other assets
Investments in capital	7,510	7,510
Long-term prepaid expenses	49,100	42,635
Deferred tax assets	363,419	389,395
Other	115,682	121,059
Allowance for doubtful accounts	△25,714	△25,654
Total investments and other assets	509,998	534,945
Total non-current assets	2,035,494	2,075,731
Total assets	18,508,245	17,371,132

		(Thousands of yen)
	As of March 31, 2022	As of June 30, 2022
Liabilities
Current liabilities
Accounts payable - trade	1,282,543	726,876
Accounts payable - other	146,856	112,255
Accrued expenses	81,284	95,700
Income taxes payable	370,527	77,359
Accrued consumption taxes	148,050	38,300
Advances received	296,351	407,903
Deposits received	9,496	50,173
Provision for bonuses	157,533	235,533
Provision for bonuses for directors (and other	21,375	21,375
officers)
Unearned revenue	114,530	141,686
Other	1,657	1,188
Total current liabilities	2,630,205	1,908,352
Non-current liabilities
Provision for retirement benefits	192,291	194,939
Provision for product warranties	63	58
Other	35,598	35,598
Total non-current liabilities	227,954	230,597
Total liabilities	2,858,160	2,138,950
Net assets
Shareholders' equity
Share capital	1,069,800	1,069,800
Capital surplus	967,926	967,926
Retained earnings	14,260,952	13,843,049
Treasury shares	△648,593	△648,593
Total shareholders' equity	15,650,085	15,232,182
Total net assets	15,650,085	15,232,182
Total liabilities and net assets	18,508,245	17,371,132